Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues. (Q46253684)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Dasatinib medication causing profound immunosuppression in a patient after haploidentical SCT: functional assays from whole blood as diagnostic clues (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

immunosuppression

1 reference

based on heuristic

inferred from title

dasatinib monohydrate

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Matthias Eyrich

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

M Wölfl

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

F Langhammer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

V Wiegering

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

P G Schlegel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

10 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

875-877

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23222377%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2012.246

0 references

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Lck is a key target of imatinib and dasatinib in T-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Profound inhibition of antigen-specific T-cell effector functions by dasatinib

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Primed tumor-reactive multifunctional CD62L+ human CD8+ T cells for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.246

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46253684&oldid=1584492865"